Varicella Zoster Infection Treatment Market

Varicella Zoster Infection Treatment Market: Purchases from Drug Stores to Rise as Demand for Topicals Take a Surge: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)

Ask The Analyst Customization Available Request Methodology

Varicella zoster spreads easily from people with chickenpox to others who never had the disease or been vaccinated. It can be transmitted by respiratory droplets, from skin lesions, by direct contact or possibly by aerosolisation of the virus from skin lesions. Chickenpox can spread from people with shingles to others who never had chickenpox or received the chickenpox vaccine. According to a study of the Centers of Disease Control and Prevention, transmission of varicella is high among household members. About 90% of varicella cases are susceptible to close contact with people suffering from varicella. In schools and day care centres the transmission rate among susceptible children tend to be lower than 30%–50%. Varicella occurs worldwide with ongoing endemic transmission in areas where the population is sufficiently large to support such transmission. 

Purchase of drugs through hospital pharmacies to increase in the coming years

Pregnant women, kids, and the geriatric population have the highest risks of developing a varicella zoster infection. As a result, if any person or kid is infected, they are either admitted or prescribed specific medicines or drugs for the treatment of the varicella zoster infection. Some of the medicines are only sold by hospital pharmacies as these medicines can only be bought if prescribed by a doctor or medical practitioner. Stringent regulations are also another reason for an increasing number of purchases from hospital pharmacies. The FDA regulatory approval process for drugs is strict. Therefore, these challenges in the regulatory environment are prompting investors in the industry to shift their investments overseas, which may act as a restraint for the growth of the varicella zoster infection treatment market. Most of the companies are facing difficulties in bringing herpes zoster drugs and vaccines to the market without the necessary FDA approvals. As a result, the approved drugs can only be bought if prescribed by a qualified healthcare professional and from specific hospital pharmacies.

varicella zoster infection treatment market

Retail pharmacies to get a boost with increasing healthcare expenditure and an advanced healthcare model

According to the IMF, global healthcare expenditure is expected to increase by over 6% yearly, based on the current GDP forecast. The rising geriatric population in developed countries and growing affluence in emerging markets are likely to boost healthcare expenditure. In the U.S., prescription drugs comprise 10% of the national health expenditure and this is expected to increase in the coming years. Besides, high spending on prescription drugs is attributed to the increased spending on new medicines, increased spending on generics, price rise of existing branded drugs, and fewer expensive blockbuster drugs going off-patent.

The governments and regulatory bodies of several countries are adopting various cost containment measures to reduce the healthcare burden, especially in developed economies. This change from a volume- to a value-based system is driven by various measures taken by the governments, healthcare providers, payers and pharmaceutical companies, which include outcome-based pricing, profit and risk sharing, price control and competitive tendering. The value-based healthcare model is expected to help achieve supreme value for money spent on healthcare and thus improve the outcomes through integrated care pathways. Nevertheless, at the same time it would levy pricing pressure on biopharmaceutical and medtech companies, which may impact R&D investment for innovative medical treatment technologies. As a result of all these factors, the demand for bulk medicines is increasing and as retail pharmacies are the best place to obtain medicines in bulk, these pharmacies are getting a good push in the global market.

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product

  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

  • Annual growth rate of current expenditure on health, per capita, in real terms

  • Out-of-pocket expenditure, % of current expenditure on health

  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

  • Physicians, Density per 1000 population (head counts)

  • Nurses, Density per 1000 population (head counts)

  • Total hospital beds, per 1000 population

  • Curative (acute) care beds, per 1000 population

  • Medical technology, Magnetic Resonance Imaging units, total, per million population

  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Standard Report Structure

  • Executive Summary

  • Market Definition

  • Macro-economic analysis

  • Parent Market Analysis

  • Market Overview

  • Forecast Factors

  • Segmental Analysis and Forecast

  • Regional Analysis

  • Competition Analysis

Market Taxonomy

Drug Type

Route of Administration

Distribution Channel

Region

  • Acyclovir

  • Valacyclovir

  • Famciclovir

  • Oral

  • Topical

  • Injectable

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

  • Drug Stores

  • North America

  • Western Europe

  • Eastern Europe

  • Latin America

  • Asia Pacific Excl. Japan (APEJ)

  • Japan

  • Middle East and Africa

 Report Methodology

The analyst has used the epidemiology model and has calculated the incidence rate among old age people, pregnant women, and children to arrive at certain assumptions about this market.

Varicella Zoster Infection Treatment Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. Wheel of Fortune

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Varicella Zoster Infection Treatment Market Opportunity Analysis 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

5. Global Economic Outlook

5.1. Disease Outlook

6. Key Inclusions

6.1. Key Manufacture List

6.2. Prescription Pattern

7. North America Varicella Zoster Infection Treatment Market Analysis 2012–2016 and  Forecast 2017–2025

7.1. Introduction

7.2. Regional Market Trends

7.3. Regional Scenario

7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

7.4.1. U.S.

7.4.2. Canada

7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

7.6.1. Acyclovir

7.6.2. Valacyclovir

7.6.3. Famciclovir

7.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

7.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

7.8.1. Oral

7.8.2. Topical

7.8.3. Injectable

7.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

7.10. Historical Market Size (US$ Mn) and Volume Trend Analysis By Distribution Channel, 2012–2016

7.10.1. Hospital Pharmacies

7.10.2. Retail Pharmacies

7.10.3. Online Pharmacies

7.10.4. Drug Stores

7.11. Market Size (US$ Mn) and Volume Forecast By Distribution Channel, 2017–2025

7.12. Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Drug Type

7.12.3. By Route of Administration

7.12.4. By Distribution Channel

7.13. Key Market Participants – Intensity Mapping

8. Latin America Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

8.1. Introduction

8.2. Regional Market Trends

8.3. Regional Scenario

8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

8.4.1. Brazil

8.4.2. Mexico

8.4.3. Rest of Latin America

8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

8.6.1. Acyclovir

8.6.2. Valacyclovir

8.6.3. Famciclovir

8.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

8.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

8.8.1. Oral

8.8.2. Topical

8.8.3. Injectable

8.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

8.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

8.10.1. Hospital Pharmacies

8.10.2. Retail Pharmacies

8.10.3. Online Pharmacies

8.10.4. Drug Stores

8.11. Market Size (US$ Mn Forecast By Distribution Channel, 2017–2025

8.12. Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Drug Type

8.12.3. By Route of Administration

8.12.4. By Distribution Channel

8.13. Key Market Participants – Intensity Mapping

9. Western Europe Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

9.1. Introduction

9.2. Regional Market Trends

9.3. Regional Scenario

9.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

9.4.1. Germany

9.4.2. U.K.

9.4.3. France

9.4.4. Italy

9.4.5. Spain

9.4.6. Rest of Western Europe

9.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

9.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

9.6.1. Acyclovir

9.6.2. Valacyclovir

9.6.3. Famciclovir

9.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

9.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

9.8.1. Oral

9.8.2. Topical

9.8.3. Injectable

9.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

9.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

9.10.1. Hospital Pharmacies

9.10.2. Retail Pharmacies

9.10.3. Online Pharmacies

9.10.4. Drug Stores

9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025

9.12. Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Drug Type

9.12.3. By Route of Administration

9.12.4. By Distribution Channel

9.13. Key Market Participants – Intensity Mapping

10. Eastern Europe Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

10.1. Introduction

10.2. Regional Market Trends

10.3. Regional Scenario

10.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

10.4.1. Russia

10.4.2. Poland

10.4.3. Rest of Eastern

10.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

10.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

10.6.1. Acyclovir

10.6.2. Valacyclovir

10.6.3. Famciclovir

10.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

10.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

10.8.1. Oral

10.8.2. Topical

10.8.3. Injectable

10.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

10.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

10.10.1.  Hospital Pharmacies

10.10.2. Retail Pharmacies

10.10.3. Online Pharmacies

10.10.4. Drug Stores

10.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025

10.12.Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Drug Type

10.12.3. By Route of Administration

10.12.4. By Distribution Channel

10.13.Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding China & Japan Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

11.1. Introduction

11.2. Regional Scenario

11.3. Regional Market Trends

11.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016

11.4.1. India

11.4.2. Australia and New Zealand

11.4.3. ASEAN

11.4.4. Rest of APECJ

11.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

11.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

11.6.1. Acyclovir

11.6.2. Valacyclovir

11.6.3. Famciclovir

11.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

11.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

11.8.1. Oral

11.8.2. Topical

11.8.3. Injectable

11.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

11.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

11.10.1.  Hospital Pharmacies

11.10.2. Retail Pharmacies

11.10.3. Online Pharmacies

11.10.4. Drug Stores

11.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025

11.12.Market Attractiveness Analysis

11.12.1. By Country

11.12.2. By Drug Type

11.12.3. By Route of Administration

11.12.4. By Distribution Channel

11.13.Key Market Participants – Intensity Mapping

12. China Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

12.1. Introduction

12.2. Key Regulations

12.3. Regional Market Trends

12.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

12.4.1. Acyclovir

12.4.2. Valacyclovir

12.4.3. Famciclovir

12.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

12.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

12.6.1. Oral

12.6.2. Topical

12.6.3. Injectable

12.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

12.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

12.8.1. Hospital Pharmacies

12.8.2. Retail Pharmacies

12.8.3. Online Pharmacies

12.8.4. Drug Stores

12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025

12.10.Market Attractiveness Analysis

12.10.1. By Country

12.10.2. By Drug Type

12.10.3. By Route of Administration

12.10.4. By Distribution Channel

12.11.Key Market Participants – Intensity Mapping

13. Japan Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

13.1. Introduction

13.2. Key Regulations

13.3. Regional Market Trends

13.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

13.4.1. Acyclovir

13.4.2. Valacyclovir

13.4.3. Famciclovir

13.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

13.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

13.6.1. Oral

13.6.2. Topical

13.6.3. Injectable

13.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

13.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

13.8.1. Hospital Pharmacies

13.8.2. Retail Pharmacies

13.8.3. Online Pharmacies

13.8.4. Drug Stores

13.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025

13.10.Market Attractiveness Analysis

13.10.1. By Country

13.10.2. By Drug Type

13.10.3. By Route of Administration

13.10.4. By Distribution Channel

13.11.Key Market Participants – Intensity Mapping

14. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

14.1. Introduction

14.2. Regional Scenario

14.3. Regional Market Trends

14.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

14.4.1. GCC Countries

14.4.2. North Africa

14.4.3. South Africa

14.4.4. Rest of MEA

14.5. Market Size (US$ Mn) Forecast By Country, 2017–2025

14.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

14.6.1. Acyclovir

14.6.2. Valacyclovir

14.6.3. Famciclovir

14.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

14.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

14.8.1. Oral

14.8.2. Topical

14.8.3. Injectable

14.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

14.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

14.10.1.  Hospital Pharmacies

14.10.2. Retail Pharmacies

14.10.3. Online Pharmacies

14.10.4. Drug Stores

14.11.Market Size (US$ Mn) By Distribution Channel, 2017–2025

14.12.Market Attractiveness Analysis

14.12.1. By Country

14.12.2. By Drug Type

14.12.3. By Route of Administration

14.12.4. By Distribution Channel

14.13.Key Market Participants – Intensity Mapping

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Competition Analysis

17.1. Competition Dashboard

17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

17.2.1. Teva Pharmaceutical Industries Ltd.

17.2.2. Abbott Laboratories

17.2.3. Sun Pharmaceuticals Industries Ltd.

17.2.4. Mylan N.V.

17.2.5. Pfizer Inc.

17.2.6. GlaxoSmithKline plc.

17.2.7. Dr. Reddy’s Laboratories, ltd.

17.2.8. Novartis AG

17.2.9. Valeant Pharmaceuticals International Inc.

18. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region

18.1. Introduction/Key Findings

18.2. Historical Market Size (US$ Mn) Analysis By Region, 2012–2016

18.3. Market Size (US$ Mn) Forecast By Region, 2017–2025

18.3.1. North America

18.3.2. Latin America

18.3.3. Western Europe

18.3.4. Eastern Europe

18.3.5. Asia Pacific Excluding China & Japan

18.3.6. China

18.3.7. Japan

18.3.8. Middle East & Africa

18.4. Market Attractiveness Analysis By Region

19. Global Varicella Zoster Infection Treatment Analysis 2012–2016 and Forecast 2017–2025, By Drug Type

19.1. Introduction/Key Findings

19.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016

19.2.1. Acyclovir

19.2.2. Valacyclovir

19.2.3. Famciclovir

19.3. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025

19.4. Market Attractiveness Analysis By Drug Type

20. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Route of Administration

20.1. Introduction/Key Findings

20.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016

20.2.1. Oral

20.2.2. Topical

20.2.3. Injectable

20.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025

20.4. Market Attractiveness Analysis By Route of Administration

21. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel

21.1. Introduction/Key Findings

21.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016

21.2.1. Hospital Pharmacies

21.2.2. Retail Pharmacies

21.2.3. Online Pharmacies

21.2.4. Drug Stores

21.3. Market Size (US$ Mn) By Distribution Channel, 2017–2025

21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025

22.1. Market Value Share Analysis By All Segment

22.2. Y-o-Y Growth Analysis By All Segment

22.3. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Varicella Zoster Infection Treatment Market Reports - List of Tables

Table 01: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 03: North America Varicella Zoster Infection Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 04: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 05: North America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 06: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 07: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 08: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn)Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 09: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 10: Latin America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 11: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 12: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 13: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 14: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 15: Western Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 16: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 17: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 18: Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 19: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 20: Eastern Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 21: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 22: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 23: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 24: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 25: APECJ Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 26: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 27: China Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 28: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 29: China Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 30: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 31: Japan Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 32: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 33: Japan Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 34: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 35: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 36: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 37: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 38: MEA Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 39: Global Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017

Table 40: Global Varicella Zoster Infection Treatment Market size Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Drug Type

Table 41: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

Table 42: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

Varicella Zoster Infection Treatment Market Reports - List of Figures

Figure 01: Global Varicella Zoster Infection Treatment  Market Value Share By Drug Type 2017 (A)

Figure 02: Global Varicella Zoster Infection Treatment  Market Value Share By Route of Administration 2017 (A)

Figure 03: Global Varicella Zoster Infection Treatment  Market Value Share By Distribution Channel 2017 (A)

Figure 04: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 05: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 06: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 07: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 8: North America Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 9: North America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 10: U.S. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 11: U.S. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 12: Canada Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 13: Canada Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 14: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 15: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 16: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 17: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 18: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 19: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 20: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 21: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 22: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 23: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 24:Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 25: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 26: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 27: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 28: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 29: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 30: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 31: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 32: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 33: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 34: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 35: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 36: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 37: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 38: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 39: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 40: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 41: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 42: Latin America Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 43: Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 44: Brazil Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 45: Brazil Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 46: Mexico Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 47: Mexico Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 48: Rest of Latin America Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2017

Figure 49: Rest of Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 50: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 51: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 52: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 53: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 54: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 55:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 56: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 57: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 58: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 59: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 60: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 61: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 62: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 63: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 64: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 65: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 66: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 67: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 68: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 69: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 70: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 71: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route ofAdministration, 2017–2027 

Figure 72: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 73: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 74: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 75: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 76: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 77: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 78: Western Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 79: Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 80: Germany Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 81: Germany Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 82: U.K. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 83: U.K. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 84: France Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 85: France Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 86: Italy Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 87: Italy Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 88: Spain Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 89: Spain Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 90: Rest of Western Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 91: Rest of Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 92: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 93: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 94: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 95: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 96: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 97:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 98: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 99: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 100: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 101: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 102: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 103: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 104: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 105: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 106: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 107: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 108: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 109: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 110: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 111: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 112: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 113: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 114: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 115: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 116: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 117: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 118: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 119: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 120: Eastern Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 121: Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 122: Russia Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 123: Russia Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 124: Poland Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 125: Poland Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 126: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 127: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 128: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 129:Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 130: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 131: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 132: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 133:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 134: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 135: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 136: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 137: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 138: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 139: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 140: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 141: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 142: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 143: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 144: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 145: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 146: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 147: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 148: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 149: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of 

Administration, 2017–2027 

Figure 150: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By DistributionChannel, 2017–2027 

Figure 151: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027   

Figure 152: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 153: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 154: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 155: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 156: APECJ Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 157: APECJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 158: India Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 159: India Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 160: Australia & New Zealand Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 161: Australia & New Zealand Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 162: ASEAN Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 163: ASEAN Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 164: Rest of APEJ Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 165: Rest of APEJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 166: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 167: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 168: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 169: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 170: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 171:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 172: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 173: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 174: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 175: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 176: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 177: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 178: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 179: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 180: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 181: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 182: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 183: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 184: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 185: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 186: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 187: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 188: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 189: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 190: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 191: Varicella Zoster Infection Treatment Market Split By Route of Administration(2017)

Figure 192: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 193: China Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 194: China Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 195: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 196: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 197: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 198: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 199: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 200:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 201: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 202: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 204: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 205: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 206: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 207: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 208: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 209: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 210: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 211: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 212: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 213: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 214: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 215: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 216: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 217: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 218: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel,2017–2027 

Figure 219: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 220: Varicella Zoster Infection Treatment Market Split By Route of Administration(2017)

Figure 221: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 222:Japan Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 223: Japan Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 224: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 225: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 226: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 227: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 228: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 229:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 230: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 231: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 232: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 233: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 234: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 235: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 236: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 237: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 238: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 239: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 240: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 241: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 242: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 243: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 244: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 245: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration,2017–2027 

Figure 246: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel,2017–2027 

Figure 247: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)

Figure 248: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)

Figure 249: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)

Figure 250: Varicella Zoster Infection Treatment Market Split By Country (2017)

Figure 251: MEA Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016

Figure 252: MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 253: GCC Countries Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 254: GCC Countries Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 255: South Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 256: South Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 257: North Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 258: North Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 259: Rest of MEA Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 260: Rest of MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 261: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 262: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 263: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 264: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 265: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 266:  Famciclovir  Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 267: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 268: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 269: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 270: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 271: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 272: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 273: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 274: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 275: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 276: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 277: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 278: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 279: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016

Figure 280: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027

Figure 281: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 282: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 283: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 284: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 285: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Region, 2017–2027 

Figure 286: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 287: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 288: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 289: Global Varicella Zoster Infection Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 290: Global Varicella Zoster Infection Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027